These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9692689)
21. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Garnett WR Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363 [TBL] [Abstract][Full Text] [Related]
22. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448 [TBL] [Abstract][Full Text] [Related]
23. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes. Dettmar PW; Sykes J; Little SL; Bryan J Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395 [TBL] [Abstract][Full Text] [Related]
25. Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom control. Mann SG; Cottrell J; Murakami A; Stauffer L; Rao AN Aliment Pharmacol Ther; 1997 Feb; 11(1):121-7. PubMed ID: 9042984 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial. Meteerattanapipat P; Phupong V Sci Rep; 2017 Mar; 7():44830. PubMed ID: 28317885 [TBL] [Abstract][Full Text] [Related]
27. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis. Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699 [TBL] [Abstract][Full Text] [Related]
28. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Mandel KG; Daggy BP; Brodie DA; Jacoby HI Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650 [TBL] [Abstract][Full Text] [Related]
29. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206 [TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Koskenpato J; Farkkilä M; Sipponen P Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319 [TBL] [Abstract][Full Text] [Related]
31. Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease. Lai IR; Wu MS; Lin JT World J Gastroenterol; 2006 Feb; 12(5):747-54. PubMed ID: 16521188 [TBL] [Abstract][Full Text] [Related]
32. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL; Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757 [TBL] [Abstract][Full Text] [Related]
33. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Cullen D; Bardhan KD; Eisner M; Kogut DG; Peacock RA; Thomson JM; Hawkey CJ Aliment Pharmacol Ther; 1998 Feb; 12(2):135-40. PubMed ID: 9692687 [TBL] [Abstract][Full Text] [Related]
34. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [TBL] [Abstract][Full Text] [Related]
35. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Jones RH; Baxter G Aliment Pharmacol Ther; 1997 Jun; 11(3):541-6. PubMed ID: 9218080 [TBL] [Abstract][Full Text] [Related]
36. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents. Quartarone G Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290 [TBL] [Abstract][Full Text] [Related]
37. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux. Poynard T; Vernisse B; Agostini H Aliment Pharmacol Ther; 1998 Feb; 12(2):159-65. PubMed ID: 9692690 [TBL] [Abstract][Full Text] [Related]
38. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease. Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584 [TBL] [Abstract][Full Text] [Related]
39. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis. Bochenek WJ; Mack ME; Fraga PD; Metz DC Aliment Pharmacol Ther; 2004 Nov; 20(10):1105-14. PubMed ID: 15569113 [TBL] [Abstract][Full Text] [Related]
40. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid]. Hotz J; Plein K; Bunke R Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]